# NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL

> **NCT04723979** · — · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 3322 (actual)

## Conditions studied

- Post Partum Hemorrhage

## Interventions

- **DRUG:** Eptacog alfa
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT04723979
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-01-31
- **Target enrollment:** 3322 (ACTUAL)
- **Last updated:** 2022-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723979, "NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04723979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*